|
1
|
Kumar R, Liu AP and Northcott PA:
Medulloblastoma genomics in the modern molecular era. Brain Pathol.
30:679–690. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Dhall G, O'Neil SH, Ji L, Haley K,
Whitaker AM, Nelson MD, Gilles F, Gardner SL, Allen JC, Cornelius
AS, et al: Excellent outcome of young children with nodular
desmoplastic medulloblastoma treated on ‘Head Start’ III: A
multi-institutional, prospective clinical trial. Neuro Oncol: Apr
18, 2020 (Epub ahead of print). doi: 10.1093/neuonc/noaa102.
|
|
3
|
Batora NV, Sturm D, Jones DT, Kool M,
Pfister SM and Northcott PA: Transitioning from genotypes to
epigenotypes: Why the time has come for medulloblastoma
epigenomics. Neuroscience. 264:171–185. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Ris MD, Packer R, Goldwein J,
Jones-Wallace D and Boyett JM: Intellectual outcome after
reduced-dose radiation therapy plus adjuvant chemotherapy for
medulloblastoma: A Children's Cancer Group study. J Clin Oncol.
19:3470–3476. 2001.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Xu W, Janss A, Packer RJ, Phillips P,
Goldwein J and Moshang T Jr: Endocrine outcome in children with
medulloblastoma treated with 18 Gy of craniospinal radiation
therapy. Neuro Oncol. 6:113–118. 2004.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hoppe-Hirsch E, Renier D, Lellouch-Tubiana
A, Sainte-Rose C, Pierre-Kahn A and Hirsch JF: Medulloblastoma in
childhood: Progressive intellectual deterioration. Childs Nerv
Syst. 6:60–65. 1990.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Chen P, Fan Y, Man TK, Hung YS, Lau CC and
Wong ST: A gene signature based method for identifying subtypes and
subtype-specific drivers in cancer with an application to
medulloblastoma. BMC Bioinformatics. 14 (Suppl
18)(S1)2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Perou CM, Sørlie T, Eisen MB, van de Rijn
M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA,
et al: Molecular portraits of human breast tumours. Nature.
406:747–752. 2000.PubMed/NCBI View
Article : Google Scholar
|
|
9
|
Sanai N: Integrated genomic analysis
identifies clinically relevant subtypes of glioblastoma. World
Neurosurg. 74:4–5. 2010.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Kool M, Koster J, Bunt J, Hasselt NE,
Lakeman A, van Sluis P, Troost D, Meeteren NS, Caron HN, Cloos J,
et al: Integrated genomics identifies five medulloblastoma subtypes
with distinct genetic profiles, pathway signatures and
clinicopathological features. PLoS One. 3(e3088)2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Yang J, Wang X, Kim M, Xie Y and Xiao G:
Detection of candidate tumor driver genes using a fully integrated
Bayesian approach. Stat Med. 33:1784–1800. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
12
|
Vogelstein B, Papadopoulos N, Velculescu
VE, Zhou S, Diaz LA Jr and Kinzler KW: Cancer genome landscapes.
Science. 339:1546–1558. 2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ohshima K, Hatakeyama K, Nagashima T,
Watanabe Y, Kanto K, Doi Y, Ide T, Shimoda Y, Tanabe T, Ohnami S,
et al: Integrated analysis of gene expression and copy number
identified potential cancer driver genes with
amplification-dependent overexpression in 1,454 solid tumors. Sci
Rep. 7(641)2017.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Akavia UD, Litvin O, Kim J, Sanchez-Garcia
F, Kotliar D, Causton HC, Pochanard P, Mozes E, Garraway LA and
Pe'er D: An integrated approach to uncover drivers of cancer. Cell.
143:1005–1017. 2010.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Son EI, Kim IM, Kim DW, Yim MB, Kang YN,
Lee SS, Kwon KY, Suh SI, Kwon TK, Lee JJ, et al:
Immunohistochemical analysis for histopathological subtypes in
pediatric medulloblastomas. Pathol Int. 53:67–73. 2003.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Aref D and Croul S: Medulloblastoma:
Recurrence and metastasis. CNS Oncol. 2:377–385. 2013.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kijima N and Kanemura Y: Molecular
Classification of Medulloblastoma. Neurol Med Chir (Tokyo).
56:687–697. 2016.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gottardo NG, Hansford JR, McGlade JP,
Alvaro F, Ashley DM, Bailey S, Baker DL, Bourdeaut F, Cho YJ, Clay
M, et al: Medulloblastoma Down Under 2013: A report from the third
annual meeting of the International Medulloblastoma Working Group.
Acta Neuropathol. 127:189–201. 2014.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ferrucci V, de Antonellis P, Pennino FP,
Asadzadeh F, Virgilio A, Montanaro D, Galeone A, Boffa I, Pisano I,
Scognamiglio I, et al: Metastatic group 3 medulloblastoma is driven
by PRUNE1 targeting NME1-TGF-β-OTX2-SNAIL via PTEN inhibition.
Brain. 141:1300–1319. 2018.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wang J, Garancher A, Ramaswamy V and
Wechsler-Reya RJ: Medulloblastoma: From molecular subgroups to
molecular targeted therapies. Annu Rev Neurosci. 41:207–232.
2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Mackall CL: In search of targeted
therapies for childhood cancer. Front Oncol. 1(18)2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kumar V, Kumar V, McGuire T, Coulter DW,
Sharp JG and Mahato RI: Challenges and recent advances in
medulloblastoma therapy. Trends Pharmacol Sci. 38:1061–1084.
2017.PubMed/NCBI View Article : Google Scholar
|
